Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2023-06-07 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of a newspaper notice about transferring unclaimed dividends and underlying equity shares to the Investor Education and Protection Fund (IEPF). It references compliance with Section 124(6) of the Companies Act, 2013 and related rules. The content is an announcement of a notice publication, not a financial report or detailed filing. The document length is about 15,000 characters, but the content is primarily a notification of a regulatory compliance action and publication of a notice, not a report or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It is an intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which typically covers disclosures about events or information that may affect the company. The document does not contain any financial data, report, or detailed presentation but simply announces the schedule of investor meetings. Given the short length (1228 characters) and the nature of the content, it is not a financial report or earnings release but an update related to investor relations. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-29 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the US FDA inspection and observations at a manufacturing facility. It is a regulatory announcement providing information about an event affecting the company, not a financial report, audit, or management discussion. The document is short (1275 characters) and serves as an official notification to stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-26 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of a Letter of Confirmation in lieu of lost/misplaced share certificates. It references SEBI regulations related to share certificate replacement. The content is a formal notification about share certificate status and does not contain financial data, management discussion, voting results, or other report types. It is an official regulatory communication related to shareholding records but does not fit into categories like Annual Report, Earnings Release, or Share Issue. Given the nature and length (1268 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-05-22 English
Annual Secretarial Compliance Report
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Certificate for the financial year ended March 31, 2023' and is issued pursuant to SEBI regulations. It is a compliance certificate issued by a Company Secretary in Practice, examining the company's adherence to various SEBI regulations during the financial year. The document includes details of compliance, deviations, fines, and management responses. It is not a full annual report or financial statement but a regulatory compliance certificate. The document length is about 15,000 characters, indicating it is a substantive report rather than a brief announcement. This type of document fits best under Regulatory Filings (RNS) as it is a compliance certificate and does not contain full financial statements or management discussion typical of Annual Reports or Interim Reports. It is not an Audit Report or a Management Report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on May 11, 2023, discussing the financial results for the quarter and fiscal year ended March 31, 2023. It includes management commentary on financial performance, business trends, and a Q&A session with investors. The text explicitly states it is a transcript of the earnings call, which is a full text record of the conference call. This matches the definition of a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive financial discussion and management remarks, consistent with a call transcript rather than a brief earnings release or announcement.
2023-05-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.